. . . . . . . . . "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain." . . . . . . "Adults" . . "2021-08-17T12:40:46.950628"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "PDUgB+9UrEizTDcCNyXR9BuvUiDg0Pr0dh0BEZNThWcDvi12T2pPJIdi1ddTVE51I+d7UAL0Nx/BErkvQ0xZ12QiTapzQiUQrn5WblfQuoVWbb3obOCueiBhTPUCHNb+GuU2Ur9agUYyN+yFIsSyigTcbKJjUAd+jB9E3tkQKW8=" . . "2021-08-17T12:40:46.950628"^^ . . .